公开(公告)号：US20240090898A1

公开(公告)日：2024-03-21

申请号：US18515669

申请日：2023-11-21

Applicant: ZipLine Medical, Inc.

Inventor： Amir Belson ,  Kei Ichiryu ,  Daren Stewart ,  Eric Storne

IPC: A61B17/08

CPC classification number: A61B17/085 ,  A61B2017/081 ,  A61B2017/086

Abstract: Devices, methods, and systems for treating an ulcer or skin defect are disclosed. First and second base panels of a closure device are adhered to first and second sides of the ulcer or skin defect, respectively. Lateral ties couple the first and second base panels together and provide a predetermined separation distance or lateral gap between the inner edges of the panel. The predetermined separation distance or lateral gap is sufficient to treat the most common sized ulcers or skin defects, for example, accommodating an ulcer or skin defect with a minor axis of at most 50 mm. The lateral ties have their ends fixed to one panel and their opposite ends adjustably and reversibly attached to the other panel so that the separation distance can be reduced or adjusted to provide a lateral compressive force to the ulcer or skin defect, thereby promoting healing.

公开(公告)号：US11864766B2

公开(公告)日：2024-01-09

申请号：US17269786

申请日：2019-08-27

Applicant: ZipLine Medical, Inc.

Inventor： Amir Belson ,  Kei Ichiryu ,  Daren Stewart ,  Eric Storne

IPC: A61B17/08

CPC classification number: A61B17/085 ,  A61B2017/081 ,  A61B2017/086

Abstract: Devices, methods, and systems for treating an ulcer or skin defect are disclosed. First and second base panels of a closure device are adhered to first and second sides of the ulcer or skin defect, respectively. Lateral ties couple the first and second base panels together and provide a predetermined separation distance or lateral gap between the inner edges of the panel. The predetermined separation distance or lateral gap is sufficient to treat the most common sized ulcers or skin defects, for example, accommodating an ulcer or skin defect with a minor axis of at most 50 mm. The lateral ties have their ends fixed to one panel and their opposite ends adjustably and reversibly attached to the other panel so that the separation distance can be reduced or adjusted to provide a lateral compressive force to the ulcer or skin defect, thereby promoting healing.

公开(公告)号：US20210196275A1

公开(公告)日：2021-07-01

申请号：US17269786

申请日：2019-08-27

Applicant: ZipLine Medical, Inc.

Inventor： Amir Belson ,  Kei Ichiryu ,  Daren Stewart ,  Eric Storne

IPC: A61B17/08

Abstract: Devices, methods, and systems for treating an ulcer or skin defect are disclosed. First and second base panels of a closure device are adhered to first and second sides of the ulcer or skin defect, respectively. Lateral ties couple the first and second base panels together and provide a predetermined separation distance or lateral gap between the inner edges of the panel. The predetermined separation distance or lateral gap is sufficient to treat the most common sized ulcers or skin defects, for example, accommodating an ulcer or skin defect with a minor axis of at most 50 mm. The lateral ties have their ends fixed to one panel and their opposite ends adjustably and reversibly attached to the other panel so that the separation distance can be reduced or adjusted to provide a lateral compressive force to the ulcer or skin defect, thereby promoting healing.

公开(公告)号：US20200275931A1

公开(公告)日：2020-09-03

申请号：US16764125

申请日：2018-11-16

Applicant: ZIPLINE MEDICAL, INC.

Inventor： Amir Belson ,  Kei Ichiryu ,  Daren Stewart ,  Eric Storne

IPC: A61B17/08 ,  A61F13/00

Abstract: Dry anti-microbial powder is applied to an incision or wound and surrounding area. A skin closure device is applied to the incision or wound. The incision or wound is closed, either before the closure device is applied or with closure device application. A sterile island dressing is then be applied over the incision or wound with the closure device and anti-microbial powder applied. The absorbent pad of the dressing can be applied directly over the incision or wound to absorb excess blood, pus, or other exudate. The anti-microbial powder mixes with the exudate before or as the exudate is absorbed. The anti-microbial powder in the exudate mixture reduces bacterial and/or microbial growth in the mixture, thereby reducing the infection risk to the closed incision or wound, as well as reducing fouling of the wound dressing and undesirable smells.